Literature DB >> 10531274

Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

E T Harvill1, P A Cotter, J F Miller.   

Abstract

We describe here a side-by-side comparison of murine respiratory infection by Bordetella pertussis and Bordetella bronchiseptica strains whose genomes are currently being sequenced (Tohama I and RB50, respectively). B. pertussis and B. bronchiseptica are most appropriately classified as subspecies. Their high degree of genotypic and phenotypic relatedness facilitates comparative studies of pathogenesis. RB50 and Tohama I differ in their abilities to grow in the nose, trachea, and lungs of BALB/c mice and to induce apoptosis, lung pathology, and an antibody response. To focus on the interactions between the bacteria and particular aspects of the host immune response, we used mice with specific immune defects. Mice lacking B cells and T cells were highly susceptible to B. bronchiseptica and were killed by intranasal inoculation with doses as low as 500 CFU. These mice were not killed by B. pertussis, even when doses as high as 10(5) CFU were delivered to the lungs. B. bronchiseptica, which was highly resistant to naive serum in vitro, caused bacteremia in these immunodeficient mice, while B. pertussis, which was highly sensitive to naive serum, did not cause bacteremia. B. bronchiseptica was, however, killed by immune serum in vitro, and adoptive transfer of anti-Bordetella antibodies protected SCID-beige mice from B. bronchiseptica lethal infection. Neutropenic mice were similarly killed by B. bronchiseptica but not B. pertussis infection, suggesting neutrophils are critical to the early inflammatory response to the former but not the latter. B. bronchiseptica was dramatically more active than B. pertussis in mediating the lysis of J774 cells in vitro and in inducing apoptosis of inflammatory cells in mouse lungs. This side-by-side comparison describes phenotypic differences that may be correlated with genetic differences in the comparative analysis of the genomes of these two highly related organisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531274      PMCID: PMC97000     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Comparative analysis of the virulence control systems of Bordetella pertussis and Bordetella bronchiseptica.

Authors:  G Martínez de Tejada; J F Miller; P A Cotter
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

2.  Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin.

Authors:  N Khelef; A Zychlinsky; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

3.  Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells.

Authors:  M Ryan; G Murphy; L Gothefors; L Nilsson; J Storsaeter; K H Mills
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

4.  BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model.

Authors:  P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host.

Authors:  P Gueirard; C Weber; A Le Coustumier; N Guiso
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

6.  Frequency of unrecognized Bordetella pertussis infections in adults.

Authors:  J G Deville; J D Cherry; P D Christenson; E Pineda; C T Leach; T L Kuhls; S Viker
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

7.  Constitutive sensory transduction mutations in the Bordetella pertussis bvgS gene.

Authors:  J F Miller; S A Johnson; W J Black; D T Beattie; J J Mekalanos; S Falkow
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

8.  Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction.

Authors:  B J Akerley; P A Cotter; J F Miller
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

9.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

Authors:  G J Lieschke; D Grail; G Hodgson; D Metcalf; E Stanley; C Cheers; K J Fowler; S Basu; Y F Zhan; A R Dunn
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

10.  Dissecting human T cell responses against Bordetella species.

Authors:  M T De Magistris; M Romano; S Nuti; R Rappuoli; A Tagliabue
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  55 in total

1.  Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract.

Authors:  Pascale Gueirard; Patrick Ave; Anne-Marie Balazuc; Sabine Thiberge; Michel Huerre; Genevieve Milon; Nicole Guiso
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.

Authors:  Mylisa R Pilione; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Authors:  Michael W Henderson; Carol S Inatsuka; Amanda J Sheets; Corinne L Williams; David J Benaron; Gina M Donato; Mary C Gray; Erik L Hewlett; Peggy A Cotter
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

5.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

6.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

7.  Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica.

Authors:  Paul B Mann; Kelly D Elder; Mary J Kennett; Eric T Harvill
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

8.  Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes.

Authors:  Trevor H Stenson; Andrew G Allen; Jehan A Al-Meer; Duncan Maskell; Mark S Peppler
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.

Authors:  Mylisa R Pilione; Eric T Harvill
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

10.  Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.

Authors:  Kelly D Elder; Eric T Harvill
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.